Small Molecule Natural Products and Alzheimer's Disease.

Curr Top Med Chem

PET Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut 06520, United States.

Published: April 2019

Alzheimer's disease (AD) is a progressive and deadly neurodegenerative disease that is characterized by memory loss, cognitive impairment and dementia. Several hypotheses have been proposed for the pathogenesis based on the pathological changes in the brain of AD patients during the last few decades. Unfortunately, there is no effective agents/therapies to prevent or control AD at present. Currently, only a few drugs, which function as acetylcholinesterase (AChE) inhibitors or N-methyl-Daspartate (NMDA) receptor antagonists, are available to alleviate symptoms. Since many small molecule natural products have shown their functions as agonists or antagonists of receptors, as well as inhibitors of enzymes and proteins in the brain during the development of central nervous system (CNS) drugs, it is likely that natural products will play an important role in anti-AD drug development. We review recent papers on using small molecule natural products as drug candidates for the treatment of AD. These natural products possess antioxidant, anti-inflammatory, anticholinesterase, anti-amyloidogenic and neuroprotective activities. Moreover, bioactive natural products intended to be used for preventing AD, reducing the symptoms of AD and the new targets for treatment of AD are summarized.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568026619666190201153257DOI Listing

Publication Analysis

Top Keywords

natural products
24
small molecule
12
molecule natural
12
alzheimer's disease
8
natural
6
products
6
products alzheimer's
4
disease alzheimer's
4
disease progressive
4
progressive deadly
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!